The low abundance of CD8+ lymphocytes in tumor samples may be due to immune checkpoint inhibition as indicated by the high expression of PD-1, PD-L2, and CTLA4 [63,64,65]. This evidence concerns the gene PDCD1LG2 and neoplasm.